ASPHALION | UKRP INFOGRAPHIC

Beginning a requirement for device registration and the introduction of the device in the United Kingdom, as of January 1st, 2021, medical device manufacturers from outside of the United Kingdom and without any local business operations must designate a United Kingdom Responsible Person (UKRP) on their behalf.

Beginning a requirement for device registration and the introduction of the device in the United Kingdom, as of January 1st, 2021, medical device manufacturers from outside of the United Kingdom and without any local business operations must designate a United Kingdom Responsible Person (UKRP) on their behalf.
August 9, 2021

➡️ Since January 1st, 2021, Medical Device manufacturers located outside the United Kingdom and without any local business offices shall appoint a United Kingdom Responsible Person (UKRP), on their behalf, as a pre-requisite for device registration and launch of the device in the United Kingdom. The UKRP acts as the point of contact between a manufacturer located outside the UK and the UK´s Medicines and Healthcare products Regulatory Agency (MHRA).

➡️ Have a look at the infographic we have prepared that summarizes the Medical Devices legal framework in UK after BREXIT, as well as the responsibilities of the UK Responisble Person and how Asphalion can help you, through its office in London, acting as your UKRP, fulfilling all obligations and keeping your Regulatory interests up to date. We have already started delivering this service to our customers and can help you along the way.

☑️ In case you would like to know more about this service, you can contact us at:

📧  ukrp@asphalion.com

👀 UKRP Infographic ⬇️

 

Search News & Events

  • Filter by category

Share

Related news and events

CTIS applicable | Faster Access to Clinical Trial Information in Europe

CTIS is the single-entry point for the submission and assessment of clinical trial applications in the EU. It features a public, searchable database aimed at delivering a high level of transparency. The authorisation and oversight of clinical trials are managed by EU/EEA Member States, while the EMA maintains the CTIS. The European Commission oversees the implementation of the Clinical Trials Regulation.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting